c-kit expression and mutations in peripheral T cell lymphomas, except for extra-nodal NK/T cell lymphomas

Leukemia and Lymphoma

Volumn 47, Issue 2, 2006, Pages 267-270

  Choe, Yee Soo ^a   Kim, Jong Gwang ^a   Sohn, Sang Kyun ^a   Kim, Dong Hwan ^a   Baek, Jin Ho ^a   Lee, Kyu Bo ^a   Do, Young Rok ^b   Kwon, Ki Young ^b   Song, Hong Suk ^b   Lee, Myung Hoon ^a   Park, Tae In ^a  

^a Kyungpook National University Hospital   (South Korea)

^b Keimyung University   (South Korea)

Author keywords

c kit; Mutation; Peripheral T cell lymphoma

Indexed keywords

ARGININE; IMATINIB; IMMUNOGLOBULIN G ANTIBODY; ISOLEUCINE; LEUCINE; MONOCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CODON; DNA SEQUENCE; DRUG TARGETING; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOBLASTIC LYMPHOMA; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; PERIPHERAL T CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR LOCALIZATION;

ADULT; AGED; EXONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 30644462092     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500281680     Document Type: Article

References (15)

1. Yarden, Y and Kuang, W and Yang-Feng, T and Coussens, L and Munemitsu, S and Dull, T and (1987) Human protooncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand EMBO Journal, 6, pp.3341-3351.
2. Qui, F and Ray, P and Brown, K and Barker, P and Jhanwar, S and Ruddle, F and (1988) Relationship with the CSF-1/PDGF receptor kinase family - oncogene activation of v-kit involves deletion of extracellular domain and C terminus EMBO Journal, 7, pp. 1003-1011.
3. Ikeda, H and Kanakura, Y and Tamaki, T and Kuriu, A and Kitayana, H and Ishikawa, J and (1991) Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells Blood, 78, pp. 2962-2968.
4. Brach, M and Buhring, H and Grub, H and Ashman, L and Ludwig, W and Mertelsmann, R and (1992) Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-∝ through posttranscriptional mRNA stabilization by a labile protein Blood, 80, pp. 1224-1230.
5. Turner, A and Zsebo, K and Martin, F and Jacobsen, F and Bennett, L and Broudy, V. (1992) Nonhematopoietic cell lines express stem cell factor and display c-kit receptors Blood, 80, pp. 374-381.
6. Ashman, L. (1999) The biology of stem cell factor and its receptor c-kit International Journal of Biochemical Cell Biology, 31, pp. 1037-1051.
7. Demetri, G and von Mehren, M and Blanke, C and Van den Abbeele, A and Eisenberg, B and Roberts, P and (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors New England Journal of Medicine, 347, pp. 472-480.
8. Pinto, A and Gloghini, A and Gattei, V and Aldinucci, D and Zagonei, V and Carbone, A. (1994) Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+anaplastic large cell lymphomas Blood, 83, pp. 785-792.
9. Hongyo, T and Li, T and Syaifudin, M and Baskar, R and Ikeda, H and Kankura, Y. (2000) Specific c-kit mutations in sinonasal natural killer/ T-cell lymphoma in China Cancer Research, 60, pp. 2345-2347.
10. Melnyk, A and Rodrguez, A and Pugh, W and Cabannillas, F. (1997) Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma Blood, 89, pp. 4514-4520.
11. Hoshida, Y and Hongyo, T and Nakatsuka, S and Nishiu, M and Takakuwa, T and Tomita, Y and (2002) Gene mutations in lymphoproliferative disorders of T and NK/T cell phenotypes developing in renal transplant patients Laboratory Investigations, 82, pp. 257-264.
12. Harris, N and Jaffe, E and Diebold, J and Flandrin, G and Muller-Hermelink, H and Vardiman, J and (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997 Journal of Clinical Oncology, 17, pp. 3835-3849
13. Harris, N and Jaffe, E and Stein, H and Banks, P and Chan, J and Cleary, M and (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group Blood, 84, pp. 1361-1392.
14. Brauns, T and Schultewolter, T and Dissemond, J and Maschke, J and Goos, M. (2004) C-KIT expression in primary cutaneous T-cell lymphomas Journal of Cutaneous Pathology, 31, pp. 577-582.
15. Tarn, C and Merkel, E and Canutescu, A and Shen, W and Skorobogatko, Y and Heslin, M and (2005) Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: Therapeutic implications through protein modeling Clinical Cancer Research, 11, pp. 3668-3677.